Lipidomic analysis of p-chlorophenylalanine-treated mice using continuous-flow two-dimensional liquid chromatography/quadrupole time-of-flight mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 29, Issue 16, 2015, Pages 1491-1500

  Weng, Rui ^a   Shen, Sensen ^a   Yang, Li ^a   Li, Min ^a   Tian, Yonglu ^b   Bai, Yu ^a   Liu, Huwei ^a  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMARKERS; LIQUID CHROMATOGRAPHY; MAMMALS; MASS SPECTROMETRY; NEURODEGENERATIVE DISEASES; PHOSPHOLIPIDS;

ALZHEIMERS DISEASE; CONTINUOUS-FLOW; LIPID BIOMARKERS; LIPIDOMICS; LIQUID CHROMATOGRAPHY-QUADRUPOLE TIME-OF-FLIGHT MASS SPECTROMETRIES; LIQUID CHROMATOGRAPHY/QUADRUPOLE-TIME OF FLIGHT MASS SPECTROMETRIES; NORMAL PHASE; PARKINSON'S DISEASE; PHYSIOLOGICAL DISORDERS; TWO-DIMENSIONAL LIQUID CHROMATOGRAPHY;

PRINCIPAL COMPONENT ANALYSIS;

BIOLOGICAL MARKER; FENCLONINE; LIPID; SEROTONIN;

ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; DEFICIENCY; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KNOCKOUT MOUSE; LIPID METABOLISM; MALE; METABOLISM; MOUSE; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; TANDEM MASS SPECTROMETRY;

ANIMALS; BIOMARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FENCLONINE; LIPID METABOLISM; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PRINCIPAL COMPONENT ANALYSIS; SEROTONIN; TANDEM MASS SPECTROMETRY;

EID: 84937800845     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.7241     Document Type: Article

References (43)

1. L. N. Squires, S. S. Rubakhin, A. A. Wadhams, K. N. Talbot, H. Nakano, L. L. Moroz, J. V. Sweedler,. Serotonin and its metabolism in basal deuterostomes: Insights from Strongylocentrotus purpuratus and Xenoturbella bocki. J. Exp. Biol. 2010, 213, 2647.
2. K. J. Ressler, C. B. Nemeroff,. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress. Anxiety 2000, 12, 2.
3. X. X. Zhuang, C. Gross, L. Santarelli, V. Compan, A. C. Trillat, R. Hen,. Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharmacology 1999, 21, S52.
4. B. Stanley, A. Molcho, M. Stanley, R. Winchel, M. J. Gameroff, B. Parsons, J. J. Mann,. Association of aggressive behavior with altered serotonergic function in patients who are not suicidal. Am. J. Psychiatry 2000, 157, 609.
5. S. F. de Boer, J. M. Koolhaas,. 5-HT1A and 5-HT1B receptor agonists and aggression: A pharmacological challenge of the serotonin deficiency hypothesis. Eur. J. Pharmacol. 2005, 526, 125.
6. J. J. Mann,. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 1999, 21, S99.
7. J. Julio Rodriguez, H. N. Noristani, A. Verkhratsky,. The serotonergic system in ageing and Alzheimer's disease. Prog. Neurobiol. 2012, 99, 15.
8. C. C. Meltzer, G. Smith, S. T. DeKosky, B. G. Pollock, C. A. Mathis, R. Y. Moore, D. J. Kupfer, C. F. Reynolds,. Serotonin in aging, late-life depression, and Alzheimer's disease: The emerging role of functional imaging. Neuropsychopharmacology 1998, 18, 407.
9. M. Bogdanov, W. R. Matson, L. Wang, T. Matson, R. Saunders-Pullman, S. S. Bressman, M. F. Beal,. Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 2008, 131, 389.
10. S. K. H. Tan, H. Hartung, T. Sharp, Y. Temel,. Serotonin-dependent depression in Parkinson's disease: A role for the subthalamic nucleus? Neuropharmacology 2011, 61, 387.
11. N. Muller, M. Schwarz,. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotoxicol. Res. 2006, 10, 131.
12. R. M. Craven, T. H. Priddle, S. J. Cooper, T. J. Crow, M. M. Esiri,. The dorsal raphe nucleus in schizophrenia: a post mortem study of 5-hydroxytryptamine neurones. Neuropathol. Appl. Neurobiol. 2005, 31, 258.
13. J. P. R. Jacobsen, I. O. Medvedev, M. G. Caron,. The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2(Arg)439(His) knockin mouse. Phil. Trans. Roy. Soc. B: Biol. Sci. 2012, 367, 2444.
14. A. A. Badawy,. Tryptophan: the key to boosting brain serotonin synthesis in depressive illness. J. Psychopharmacol. (Oxford, England) 2013, 27, 878.
15. G. Aghajanian,. Electrophysiology of Serotonin Receptor Subtypes and Signal Transduction Pathways. Raven Press, New York, 1995.
16. A. Mansour, J. Meador-Woodruff, J. Lopez, S. Watson,. Biochemical Anatomy: Insights into the Cell Biology and Pharmacology of the Dopamine and Serotonin Systems in the Brain, (2nd edn.). American Psychiatric Press, Washington, 1998.
17. K. P. Su, W. W. Shen, S. Y. Huang,. Effects of polyunsaturated fatty acids on psychiatric disorders. Am. J. Clin. Nutr. 2000, 72, 1241.
18. J. Kornhuber, M. Reichel, P. Tripal, T. W. Groemer, A. W. Henkel, C. Muhle, E. Gulbins,. The role of ceramide in major depressive disorder. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259 Suppl 2, S199.
19. A. A. Farooqui, L. A. Horrocks, T. Farooqui,. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem. Phys. Lipids 2000, 106, 1.
20. M. R. Wenk,. The emerging field of lipidomics. Nat. Rev. Drug Discov. 2005, 4, 594.
21. M. R. Wenk,. Lipidomics: New tools and applications. Cell 2010, 143, 888.
22. Y. Hirowatari, K. Hara, Y. Shimura, H. Takahashi,. Serotonin levels in platelet-poor plasma and whole blood from healthy subjects: Relationship with lipid markers and coronary heart disease risk score. J. Atheroscler. Thromb. 2011, 18, 874.
23. M. Li, X. Tong, P. Lv, B. Feng, L. Yang, Z. Wu, X. Cui, Y. Bai, Y. Huang, H. Liu,. A not-stop-flow online normal-/reversed-phase two-dimensional liquid chromatography-quadrupole time-of-flight mass spectrometry method for comprehensive lipid profiling of human plasma from atherosclerosis patients. J. Chromatogr. A 2014, 1372, 110.
24. B. K. Koe, A. Weissman,. p-Chlorophenylalanine-a specific depletor of brain serotonin. J. Pharmacol. Exp. Ther. 1966, 154, 499.
25. E. Jequier, W. Lovenber, A. Sjoerdsm,. Tryptophan hydroxylase inhibition-mechanism by which p-chlorophenylalanine depletes rat brain serotonin. Mol. Pharmacol. 1967, 3, 274.
26. Y. Liu, Y. a. Jiang, Y. Si, J.-Y. Kim, Z.-F. Chen, Y. Rao,. Molecular regulation of sexual preference revealed by genetic studies of 5-HT in the brains of male mice. Nature 2011, 472, 95.
27. J. Folch, M. Lees, G. H. Sloane Stanley,. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497.
28. H. G. Gika, G. A. Theodoridis, J. E. Wingate, I. D. Wilson,. Within-day reproducibility of an HPLC-MS-Based method for metabonomic analysis: Application to human urine. J. Proteome Res. 2007, 6, 3291.
29. J. L. Nugent, A. N. McCoy, C. J. Addamo, W. Jia, R. S. Sandler, T. O. Keku,. Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas. J. Proteome Res. 2014, 13, 1921.
30. K. Engelman, W. Lovenber, A. Sjoerdsm,. Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with carcinoid syndrome. N. Engl. J. Med. 1967, 277, 1103.
31. S. Bijlsma, L. Bobeldijk, E. R. Verheij, R. Ramaker, S. Kochhar, I. A. Macdonald, B. van Ommen, A. K. Smilde,. Large-scale human metabolomics studies: A strategy for data (pre-) processing and validation. Anal. Chem. 2006, 78, 567.
32. H. G. Nie, R. R. Liu, Y. Y. Yang, Y. Bai, Y. F. Guan, D. Q. Qian, T. Wang, H. W. Liu,. Lipid profiling of rat peritoneal surface layers by online normal- and reversed-phase 2D LC QToF-MS. J. Lipid Res. 2010, 51, 2833.
33. M. Li, B. S. Feng, Y. Liang, W. Zhang, Y. Bai, W. Tang, T. Wang, H. W. Liu,. Lipid profiling of human plasma from peritoneal dialysis patients using an improved 2D (NP/RP) LC-QToF MS method. Anal. Bioanal. Chem. 2013, 405, 6629.
34. D. Y. Chen, X. J. Yan, J. L. Xu, X. L. Su, L. J. Li,. Lipidomic profiling and discovery of lipid biomarkers in Stephanodiscus sp under cold stress. Metabolomics 2013, 9, 949.
35. V. Frisardi, F. Panza, D. Seripa, T. Farooqui, A. A. Farooqui,. Glycerophospholipids and glycerophospholipid-derived lipid mediators: A complex meshwork in Alzheimer's disease pathology. Prog. Lipid Res. 2011, 50, 313.
36. R. Kaddurah-Daouk, J. McEvoy, R. Baillie, H. Zhu, J. K. Yao, V. L. Nimgaonkar, P. F. Buckley, M. S. Keshavan, A. Georgiades, H. A. Nasrallah,. Impaired plasmalogens in patients with schizophrenia. Psychiatry Res. 2012, 198, 347.
37. M. M. Mielke, W. Maetzler, N. J. Haughey, V. V. R. Bandaru, R. Savica, C. Deuschle, T. Gasser, A.-K. Hauser, S. Graeber-Sultan, E. Schleicher, D. Berg, I. Liepelt-Scarfone,. Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: A pilot study. Plos One 2013, 8.
38. R. E. Pagano,. What is the fate of diacylglycerol produced at the Golgi apparatus. Trends Biochem. Sci. 1988, 13, 202.
39. P. Singh, Y. D. Paila, A. Chattopadhyay,. Role of glycosphingolipids in the function of human serotonin1(A) receptors. J. Neurochem. 2012, 123, 716.
40. R. G. Cutler, N. J. Haughey, A. Tammara, J. C. McArthur, A. Nath, R. Reid, D. L. Vargas, C. A. Pardo, M. P. Mattson,. Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia. Neurology 2004, 63, 626.
41. M. O. W. Grimm, H. S. Grimm, A. J. Patzold, E. G. Zinser, R. Halonen, M. Duering, J. A. Tschape, B. De Strooper, U. Muller, J. Shen, T. Hartmann,. Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat. Cell. Biol. 2005, 7, 1118.
42. M. G. Schlossmacher, V. Cullen, J. Muthing,. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 2005, 352, 729.
43. D. Cheng, A. M. Jenner, G. Shui, W. F. Cheong, T. W. Mitchell, J. R. Nealon, W. S. Kim, H. McCann, M. R. Wenk, G. M. Halliday, B. Garner,. Lipid pathway alterations in Parkinson's disease primary visual cortex. Plos One 2011, 6.